Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Farmers Insurance
Teva
UBS
Cerilliant
Express Scripts
Healthtrust
Cantor Fitzgerald

Generated: August 18, 2017

DrugPatentWatch Database Preview

Cabergoline - Generic Drug Details

« Back to Dashboard

What are the generic sources for cabergoline and what is the scope of cabergoline patent protection?

Cabergoline
is the generic ingredient in two branded drugs marketed by Apotex Corp, Par Pharm, Actavis Labs Fl Inc, Impax Labs Inc, Mylan Pharms Inc, Ivax Sub Teva Pharms, and Pharmacia And Upjohn, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for cabergoline. Six suppliers are listed for this compound.

Summary for Generic Name: cabergoline

Tradenames:2
Patents:0
Applicants:7
NDAs:7
Drug Master File Entries: see list11
Suppliers / Packagers: see list6
Bulk Api Vendors: see list29
Clinical Trials: see list41
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cabergoline at DailyMed

Pharmacology for Ingredient: cabergoline

Ingredient-typeErgolines
Drug ClassErgot Derivative
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
CABERGOLINE
cabergoline
TABLET;ORAL076310-001Dec 29, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe
Impax Labs Inc
CABERGOLINE
cabergoline
TABLET;ORAL077843-001Jul 3, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CABERGOLINE
cabergoline
TABLET;ORAL202947-001Dec 2, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DOSTINEX
cabergoline
TABLET;ORAL020664-001Dec 23, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
CABERGOLINE
cabergoline
TABLET;ORAL077750-001Mar 7, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cabergoline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DOSTINEX
cabergoline
TABLET;ORAL020664-001Dec 23, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Teva
Healthtrust
Citi
Farmers Insurance
US Army
Accenture
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot